SCHEMBL5598237

SCHEMBL5598237

NC(=O)c1ccccc1C(O)C1CCCCCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.48
NPC1 O15118 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
SIRT2 Q8IXJ6 1/20 0.41
RPS6KB1 P23443 1/20 0.41
METAP2 P50579 4/20 0.40
METAP1 P53582 2/20 0.40
DPP4 P27487 1/20 0.40
DPP8 Q6V1X1 1/20 0.40
DPP9 Q86TI2 1/20 0.40
DPP7 Q9UHL4 1/20 0.40
DHODH Q02127 1/20 0.40
KDM4E B2RXH2 3/20 0.40
ALDH1A1 P00352 2/20 0.40
HPGD P15428 2/20 0.40
HTT P42858 2/20 0.40
LMNA P02545 1/20 0.40
RAB9A P51151 1/20 0.40
IRAK4 Q9NWZ3 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5598468 1.00 TP53 (0.48) TP53NPC1MEN1KMT2ASIRT2
SCHEMBL6171265 1.00 TP53 (0.48) TP53NPC1MEN1KMT2ASIRT2
SCHEMBL6170527 0.95 TP53 (0.42) TP53NPC1MEN1KMT2ASIRT2
SCHEMBL6072932 0.82 TP53 (0.46) TP53NPC1MEN1KMT2ASIRT2
SCHEMBL3720389 0.80 ALDH1A1 (0.44) MEN1KMT2AKDM4EALDH1A1HPGD
SCHEMBL5598341 0.79 TP53 (0.44) TP53NPC1MEN1KMT2ASIRT2
SCHEMBL5598180 0.76 HTR1E (0.42) TP53NPC1MEN1KMT2ARPS6KB1
SCHEMBL5171003 0.75 TP53 (0.40) TP53MEN1KMT2AMETAP2METAP1
SCHEMBL28064364 0.74 GABRA1 (0.42) NPC1MEN1KMT2AMETAP2DHODH
SCHEMBL8036927 0.74 GABRA1 (0.42) NPC1MEN1KMT2AMETAP2DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1763353-A1 COMBINATION THERAPIES UTILIZING BENZAMIDE INHIBITORS OF THE P2X<sb>7</sb> RECEPTOR Warner-Lambert Company LLC (US) 2007-03-21 EP disclosed
WO-2006003517-A1 COMBINATION THERAPIES UTILIZING BENZAMIDE INHIBITORS OF THE P2X7 RECEPTOR WARNER-LAMBERT COMPANY LLC (US) 2006-01-12 WO disclosed
EP-1581232-A1 3-(3,5-DIOXO-4,5-DIHYDRO-3H-(1,2,4)TRIAZIN-2-YL)-BENZAMIDE DERIVATIVES AS P2X7-INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES Pfizer Products Inc. (US) 2005-10-05 EP disclosed
EP-1581507-A1 BENZAMIDE INHIBITORS OF THE P2X7 RECEPTOR Pfizer Products Inc. (US) 2005-10-05 EP disclosed
WO-2004058731-A1 BENZAMIDE INHIBITORS OF THE P2X7 RECEPTOR PFIZER PRODUCTS INC. (US) 2004-07-15 WO disclosed
WO-2004058270-A1 3-(3,5-DIOXO-4,5-DIHYDRO-3H-(1,2,4)TRIAZIN-2-YL)-BENZAMIDE DERIVATIVES AS P2X7-INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES PFIZER PRODUCTS INC. (US) 2004-07-15 WO disclosed